Transcat, Inc. (NASDAQ:TRNS) – Equities research analysts at Dougherty & Co issued their FY2019 EPS estimates for shares of Transcat in a research report issued on Monday. Dougherty & Co analyst R. Ryan anticipates that the scientific and technical instruments company will post earnings of $0.73 per share for the year.

TRNS has been the topic of a number of other reports. Zacks Investment Research lowered shares of Transcat from a “hold” rating to a “sell” rating in a report on Wednesday, December 20th. Singular Research started coverage on shares of Transcat in a report on Wednesday, November 15th. They issued a “buy” rating and a $15.30 target price on the stock.

Transcat (NASDAQ TRNS) traded down $0.55 during trading hours on Thursday, reaching $13.50. 24,074 shares of the company’s stock were exchanged, compared to its average volume of 50,100. The stock has a market cap of $100.74, a price-to-earnings ratio of 22.13, a price-to-earnings-growth ratio of 3.39 and a beta of 0.45. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.53 and a current ratio of 2.24. Transcat has a 52 week low of $10.49 and a 52 week high of $15.15.

A number of large investors have recently added to or reduced their stakes in the business. Northern Trust Corp lifted its holdings in Transcat by 9.5% in the 2nd quarter. Northern Trust Corp now owns 18,062 shares of the scientific and technical instruments company’s stock valued at $220,000 after purchasing an additional 1,570 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Transcat by 3.4% during the 2nd quarter. Vanguard Group Inc. now owns 133,579 shares of the scientific and technical instruments company’s stock valued at $1,623,000 after acquiring an additional 4,450 shares during the last quarter. Neuberger Berman Group LLC increased its stake in shares of Transcat by 3.1% during the 2nd quarter. Neuberger Berman Group LLC now owns 164,993 shares of the scientific and technical instruments company’s stock valued at $2,005,000 after acquiring an additional 4,900 shares during the last quarter. QCI Asset Management Inc. NY increased its stake in shares of Transcat by 31.1% during the 3rd quarter. QCI Asset Management Inc. NY now owns 32,234 shares of the scientific and technical instruments company’s stock valued at $437,000 after acquiring an additional 7,647 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in shares of Transcat by 3.1% during the 3rd quarter. Dimensional Fund Advisors LP now owns 290,146 shares of the scientific and technical instruments company’s stock valued at $3,960,000 after acquiring an additional 8,771 shares during the last quarter. Institutional investors own 56.69% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This news story was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright law. The original version of this news story can be read at https://www.americanbankingnews.com/2018/01/04/research-analysts-offer-predictions-for-transcat-inc-s-fy2019-earnings-trns.html.

Transcat Company Profile

Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.